CME · News · 20260824N

Leverage Trading Regulatory Risk

CME GROUP INC. · 2026-08-24 · Importance 13 · Surprise 24

A reported comment by President Trump concerning a crypto exchange has triggered a regulatory debate over whether U.S. retail investors could access up to 50x leverage on stock exposure. The issue could affect products referencing the S&P 500 and the broader derivatives-market framework. CME’s CEO warned that such leverage could destabilize markets, highlighting potential regulatory and market-structure risks for CME.

Key facts

• CME's CEO is warning it could break the market in response to a regulatory fight about whether ordinary Americans can legally bet on the S&P 500 with 50x leverage. source
• CME identified regulatory tailwinds in clearing requirements as a key catalyst for growth. source